My research program is focused on using new methods to stimulate immune response in patients with cancer and as a means to prevent infectious diseases. The first clinical application of new technology developed in my lab is for treatment of patients with advanced stage ovarian cancer. In addition, my group is focused on developing methods to generate new vaccine candidates for infectious diseases in humans and animals. Our current program of work includes research on new vaccine formulations for SARS-CoV-2, Tuberculosis, Influenza and African Swine Fever, using a technology platform for production of vaccines that I invented with colleagues at Colorado State University.